Medical Technology

Nuwellis has secured approximately $5 million in gross proceeds through a private placement and warrant inducement. The company sold common stock or pre-funded warrants alongside private placement warrants. Additionally, existing warrants were exercised, and new warrants were issued at a lower strike price. This financing is intended to bolster Nuwellis’s balance sheet, supporting research, development, and operational expenditures in the cardiorenal care sector.

Avanos Medical CEO Dave Pacitti will present at the 44th Annual J.P. Morgan Healthcare Conference on January 13th. He will discuss the company’s strategic vision and innovations in medical devices, focusing on patient recovery, nutritional support, and reducing opioid reliance. Avanos aims to empower patients to regain mobility and return to fulfilling lives. The presentation will be webcast on the Avanos Medical website.

STAAR Surgical’s special stockholder meeting regarding the Alcon merger has been postponed to January 6, 2026. This decision, initiated by Alcon, delays the vote on the acquisition. STAAR, known for its EVO ICL vision correction technology, faces a complex M&A landscape. Investors are advised to consult SEC filings and the proxy statement for crucial details as the new meeting date approaches.

GE HealthCare’s CFO, Jay Saccaro, will present at the Jefferies Global Healthcare Conference on November 18, 2025. The presentation will cover GE HealthCare’s business strategy and growth opportunities amidst evolving healthcare market dynamics. Saccaro is expected to address the impact of a competitor’s FDA approval and reassure investors about GE HealthCare’s competitive position. He will likely highlight the company’s strengths, including global presence, diverse portfolio, and investments in AI and cloud technologies. A live webcast will be available on the GE HealthCare investor relations website.

Masimo (MASI) won a U.S. District Court case against Apple, with a jury confirming the validity of Masimo’s Patent No. 10,433,776 and finding Apple infringed upon it. Masimo was awarded $634 million in damages. The patent covers light-based pulse oximetry technology. Masimo expressed satisfaction, emphasizing the importance of protecting their intellectual property. Analysts suggest this verdict could set a precedent for licensing agreements in the wearable health technology sector.